56
https://pubmed.ncbi.nlm.nih.gov/38116408
This abstract describes the discovery and potential therapeutic use of novel pyrido[3,2-d]pyrimidines as HPK1 inhibitors for treating cancer and inflammatory and autoimmune diseases.